BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1674536)

  • 1. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
    Mandal AK; Kellar KJ; Gillis RA
    J Pharmacol Exp Ther; 1991 May; 257(2):861-9. PubMed ID: 1674536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
    Mandal AK; Kellar KJ; Friedman E; Pineo SV; Hamosh P; Gillis RA
    J Pharmacol Exp Ther; 1989 Nov; 251(2):563-70. PubMed ID: 2530339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors.
    Mandal AK; Zhong PY; Kellar KJ; Gillis RA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S49-60. PubMed ID: 1702487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive effect of urapidil: CNS site and relative contribution.
    Gillis RA; Dretchen KL; Namath I; Anastasi N; Dias Souza J; Hill K; Browne RK; Quest JA
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):103-9. PubMed ID: 2434784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
    Gillis RA; Hill KJ; Kirby JS; Quest JA; Hamosh P; Norman WP; Kellar KJ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):851-7. PubMed ID: 2521902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system site of action for the hypotensive effect of clonidine in the cat.
    Gatti PJ; Hill KJ; Da Silva AM; Norman WP; Gillis RA
    J Pharmacol Exp Ther; 1988 Apr; 245(1):373-80. PubMed ID: 2896240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
    Sanders KH; Beller KD; Kolassa N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors.
    Ramage AG
    Br J Pharmacol; 1991 Apr; 102(4):998-1002. PubMed ID: 1855130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of urapidil with brain serotonin-1A receptors increases the blood pressure reduction due to peripheral alpha-adrenoceptor inhibition.
    Sanders KH; Beller KD; Bischler P; Kolassa N
    J Hypertens Suppl; 1988 Dec; 6(2):S65-8. PubMed ID: 2906703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies on the neurocardiovascular effects of urapidil.
    Gillis RA; Kellar KJ; Quest JA; Namath IJ; Martino-Barrows A; Hill K; Gatti PJ; Dretchen K
    Drugs; 1988; 35 Suppl 6():20-33. PubMed ID: 2900129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
    Valenta B; Kotai E; Weisz E; Singer EA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    Goering J; Zimmerman BG
    J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ; Quest JA; Spera AC; Buller A; Conforti A; Dias Souza J; Gillis RA
    Am J Med; 1984 Oct; 77(4A):87-95. PubMed ID: 6091452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of alpha-2 adrenergic receptors in the rostral ventrolateral medulla attenuates the sympathoinhibitory response to cocaine.
    Abrahams TP; Liu W; Varner KJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):967-74. PubMed ID: 8930206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urapidil on blood pressure and adrenoceptors in various animal models.
    van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB
    J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
    Dabiré H; Laubie M; Schmitt H
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
    Gillis RA; Namath IJ; Easington C; Abrahams TP; Guidotti A; Quest JA; Hamosh P; Taveira da Silva AM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):863-70. PubMed ID: 2537419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of the hypotensive action of urapidil.
    Bousquet P; Feldman J; Schwartz J
    J Hypertens Suppl; 1985 Dec; 3(3):S187-9. PubMed ID: 2856701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.